19-20006097-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_033196.3(ZNF682):āc.1405A>Gā(p.Asn469Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00068 in 1,614,010 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_033196.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF682 | NM_033196.3 | c.1405A>G | p.Asn469Asp | missense_variant | 4/4 | ENST00000397165.7 | NP_149973.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF682 | ENST00000397165.7 | c.1405A>G | p.Asn469Asp | missense_variant | 4/4 | 2 | NM_033196.3 | ENSP00000380351.1 |
Frequencies
GnomAD3 genomes AF: 0.000453 AC: 69AN: 152260Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000601 AC: 150AN: 249594Hom.: 0 AF XY: 0.000665 AC XY: 90AN XY: 135410
GnomAD4 exome AF: 0.000704 AC: 1029AN: 1461750Hom.: 1 Cov.: 31 AF XY: 0.000745 AC XY: 542AN XY: 727162
GnomAD4 genome AF: 0.000453 AC: 69AN: 152260Hom.: 0 Cov.: 33 AF XY: 0.000363 AC XY: 27AN XY: 74400
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 06, 2021 | The c.1405A>G (p.N469D) alteration is located in exon 4 (coding exon 4) of the ZNF682 gene. This alteration results from a A to G substitution at nucleotide position 1405, causing the asparagine (N) at amino acid position 469 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at